Ascent Group’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,935	Closed	-$784K	–	556
2024 Q3	$784K	Buy	+7,935	New	+$784K	0.06%	316
2022 Q2	–	Sell	-23,536	Closed	-$2.12M	–	510
2022 Q1	$2.12M	Buy	+23,536	New	+$2.12M	0.25%	142